These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21451411)

  • 21. Treatment of autoimmune hepatitis: a review of current and evolving therapies.
    Jothimani D; Cramp ME; Mitchell JD; Cross TJ
    J Gastroenterol Hepatol; 2011 Apr; 26(4):619-27. PubMed ID: 21073674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
    Inductivo-Yu I; Adams A; Gish RG; Wakil A; Bzowej NH; Frederick RT; Bonacini M
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Auto-immune hepatitis: therapeutic management].
    Pariente A
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B13-9. PubMed ID: 12843932
    [No Abstract]   [Full Text] [Related]  

  • 24. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis.
    Brunt EM; Di Bisceglie AM
    Hum Pathol; 2004 Apr; 35(4):509-12. PubMed ID: 15116334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and therapy of autoimmune hepatitis.
    Granito A; Muratori P; Ferri S; Pappas G; Quarneti C; Lenzi M; Bianchi FB; Muratori L
    Mini Rev Med Chem; 2009 Jun; 9(7):847-60. PubMed ID: 19519509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-line Agents in Pediatric Patients With Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
    Zizzo AN; Valentino PL; Shah PS; Kamath BM
    J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):6-15. PubMed ID: 28644343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis.
    Hanouneh M; Ritchie MM; Ascha M; Ascha MS; Chedid A; Sanguankeo A; Zein NN; Hanouneh IA
    Scand J Gastroenterol; 2019 Jan; 54(1):76-80. PubMed ID: 30650311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I.
    Czaja AJ
    Inflamm Allergy Drug Targets; 2012 Oct; 11(5):337-50. PubMed ID: 22563779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment.
    Rigopoulou EI; Gyftaki S; Arvaniti P; Tsimourtou V; Koukoulis GK; Hadjigeorgiou G; Dalekos GN
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):e25-e32. PubMed ID: 30594597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protocol of a prospective study for the combination treatment of Shu-Gan-jian-Pi decoction and steroid standard therapy in autoimmune hepatitis patients.
    Chi XL; Xiao HM; Xie YB; Cai GS; Jiang JM; Tian GJ; Shi MJ; Wu SD; Zhao PT; Chen HJ
    BMC Complement Altern Med; 2016 Dec; 16(1):505. PubMed ID: 27923369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management.
    Rizvi S; Gawrieh S
    Drugs Aging; 2018 Jul; 35(7):589-602. PubMed ID: 29971609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug choices in autoimmune hepatitis: part B--Nonsteroids.
    Czaja AJ
    Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):617-35. PubMed ID: 23061712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and treatment of autoimmune hepatitis].
    Verwer BJ; Bouma G; Bloemena E; Schreuder TC; Mulder CJ; van Nieuwkerk KM
    Ned Tijdschr Geneeskd; 2009; 153():A247. PubMed ID: 19900315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and management of autoimmune hepatitis.
    Czaja AJ
    Clin Liver Dis; 2015 Feb; 19(1):57-79. PubMed ID: 25454297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune hepatitis: diagnosis, treatment, and prognosis.
    Luxon BA
    Curr Gastroenterol Rep; 2006 Feb; 8(1):83-8. PubMed ID: 16510039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractory Autoimmune Hepatitis: Beyond Standard Therapy.
    Rubin JN; Te HS
    Dig Dis Sci; 2016 Jun; 61(6):1757-62. PubMed ID: 26725067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Autoimmune hepatitis: new diagnostic and therapeutic approach].
    Prelipcean CC; Mihai C; Stefănescu C; Drug VL
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):32-9. PubMed ID: 15688753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.
    Park SW; Um SH; Lee HA; Kim SH; Sim Y; Yim SY; Seo YS; Ryu HS
    Clin Mol Hepatol; 2016 Jun; 22(2):281-5. PubMed ID: 27246353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis.
    Hlivko JT; Shiffman ML; Stravitz RT; Luketic VA; Sanyal AJ; Fuchs M; Sterling RK
    Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1036-40. PubMed ID: 18586559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.